Charles Schwab Investment Management »

Keros Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.2M 182k 39.76
2023-09-30 $5.6M 177k 31.88
2023-06-30 $5.9M 148k 40.18
2023-03-31 $5.7M 133k 42.70
2022-12-31 $6.4M 133k 48.02
2022-09-30 $4.6M 122k 37.63
2022-06-30 $2.8M 102k 27.64
2022-03-31 $5.5M 101k 54.39
2021-12-31 $5.8M 98k 58.51
2021-09-30 $3.9M 99k 39.57
2021-06-30 $3.3M 79k 42.48
2021-03-31 $3.6M 58k 61.55
2020-12-31 $3.9M 56k 70.55
2020-09-30 $1.7M 44k 38.59
2020-06-30 $1.6M 43k 37.53